哌拉西林游离分数波动对重症患者给药推荐的影响
该研究基于外部数据,对持续输注哌拉西林的总浓度分别应用70%、75%、80%、85%的游离分数,评估群体药动学模型预测性能及给药达标情况。结果显示游离分数波动对哌拉西林清除率和靶标 attainment 影响极小,但可能影响模型有效性。
要点
- 游离分数在70%–85%间波动对哌拉西林清除率影响极小。
- 游离分数波动对持续输注哌拉西林的靶标达标率影响有限。
- 游离分数变异可能影响群体药动学模型的有效性评估。
核心结论
- 哌拉西林游离分数在70%至85%间波动对清除率和靶标 attainment 影响极小,但可能影响模型有效性。
研究设计与样本
- 基于外部数据集,对持续输注哌拉西林的总浓度应用70%、75%、80%、85%的游离分数,使用已验证模型评估预测性能并估算患者清除率,并进行给药模拟评估靶标达标。
主要发现
- 游离分数变异对哌拉西林清除率影响极小。
- 游离分数变异对靶标达标影响极小。
- 游离分数变异似乎影响模型有效性。
临床怎么用
- 重症患者使用哌拉西林持续输注时,基于总浓度结合理论游离分数估算游离浓度的常见做法受游离分数波动影响较小。
- 需关注低白蛋白血症等导致游离分数变异的情况对药动学模型有效性的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A common approach to assess the efficacy of piperacillin is to first measure the total concentration and afterwards apply a theoretical unbound fraction of 70% to obtain the unbound concentration. However, hypoalbuminemia is a common phenomenon in critically ill patients, resulting in variations in unbound fraction, therefore we aimed to simulate the impact of piperacillin unbound fraction fluctuations on the predictive performance of a population pharmacokinetic model and on the dosing recommendations of piperacillin. Unbound factors of 70%, 75%, 80% and 85% were applied to total concentrations of piperacillin administered by continuous infusion from an external dataset. A validated model was used for assessment of predictive performance and to estimate patient clearance. Dosing simulations were performed to evaluate target attainment. Variation in unbound fractions caused minimal impact on piperacillin clearance and target attainment but seemed to influence model validity.
引用
- El-Haffaf I, Guilhaumou R, Velly L, et al. Impact of piperacillin unbound fraction variability on dosing recommendations in critically ill patients. Br J Clin Pharmacol. 2022. PMID: 36445340. doi:10.1111/bcp.15619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。